Santeon and MEB exchange info about prescription of medicinal products

30 January 2017

In the coming year, the Netherlands’ Medicines Evaluation Board (MEB) and hospitals affiliated with Santeon will exchange anonymous information about prescription of medicines in top clinical hospitals.

Santeon collects this information for the seven Santeon hospitals, which may provide the MEB with valuable insights on use and experiences with medicines in daily practice. For instance, the information may be of use to find other solutions in the event of a possible medicine shortage.

Santeon is a cooperative venture between seven top clinical hospitals and aims to improve medical care through continuous innovation. One such effort is the creation of the Pharma Database, containing information on all the medicines issued in the affiliated hospitals. Through this database, the hospitals want to ensure more efficient use of medicines.

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK